Literature DB >> 21896860

Association of genetic variation on chromosome 9p21 with polypoidal choroidal vasculopathy and neovascular age-related macular degeneration.

Xiongze Zhang1, Feng Wen, Chengguo Zuo, Meng Li, Hui Chen, Kunfang Wu.   

Abstract

PURPOSE: Polypoidal choroidal vasculopathy (PCV) contains aneurismal morphologic and histopathologic feature and it is considered to be a possible distinct entity from neovascular age-related macular degeneration (AMD). In this study, the association of identified risk variants for intracranial aneurysm on chromosome 9p21 with PCV and neovascular AMD in a Chinese Han population was investigated.
METHODS: The authors genotyped rs1333040 and rs10757278 on 9p21 in 177 PCV patients, 131 neovascular AMD patients, and 182 controls using a genotyping method and direct DNA sequencing. Allele and genotypes frequencies in the PCV and neovascular AMD groups were compared with controls using a free open-source software and binary logistic regression analysis.
RESULTS: Rs1333040 was not associated with PCV or neovascular AMD. Rs10757278 was significantly associated with PCV [risk allele: A, P (allelic) = 0.014; odds ratio = 1.44; 95% confidence interval, 1.08-1.94], but not associated with neovascular AMD. After adjusting for sex, age, smoking status, history of hypertension, type 2 diabetes, and coronary artery disease, the odds ratio for homozygous carriers of rs10757278-A was 2.10 (95% confidence interval, 1.14-3.85) for PCV.
CONCLUSIONS: The rs10757278 on chromosome 9p21 is significantly associated with the risk of PCV but not with neovascular AMD in the Chinese Han population.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21896860     DOI: 10.1167/iovs.11-7820

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  11 in total

1.  Genetic risk, ethnic variations and pharmacogenetic biomarkers in age-related macular degeneration and polypoidal choroidal vasculopathy.

Authors:  Jane Z Kuo; Tien Y Wong; Frank S Ong
Journal:  Expert Rev Ophthalmol       Date:  2013-04-01

2.  Age-related differences in the prevalence of subtypes of Neovascular age-related macular degeneration in the first diagnosed eye.

Authors:  Jae Hui Kim; Young Suk Chang; Jong Woo Kim; Chul Gu Kim; Dong Won Lee
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-01-07       Impact factor: 3.117

3.  Association of HERPUD1 genetic variant rs2217332 with age-related macular degeneration and polypoidal choroidal vasculopathy in an Indian cohort.

Authors:  Lakshmi Priyankka Alagappan; Yazhini Ramaswamy; Deepak Kumar Sundaramoorthy; Joshitha Bhaskar; Sripriya Sarangapani; Parveen Sen; Rajiv Raman; Muna Bhende; Sinnakaruppan Mathavan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-10-12       Impact factor: 3.535

Review 4.  Genetic insights into age-related macular degeneration: controversies addressing risk, causality, and therapeutics.

Authors:  Michael B Gorin
Journal:  Mol Aspects Med       Date:  2012-04-27

Review 5.  Genetic associations in polypoidal choroidal vasculopathy: a systematic review and meta-analysis.

Authors:  Haoyu Chen; Ke Liu; Li Jia Chen; Ping Hou; Weiqi Chen; Chi Pui Pang
Journal:  Mol Vis       Date:  2012-04-04       Impact factor: 2.367

6.  COL1A2 polymorphic markers confer an increased risk of neovascular age-related macular degeneration in a Han Chinese population.

Authors:  Chengguo Zuo; Feng Wen; Meng Li; Xiongze Zhang; Hui Chen; Kunfang Wu; Renpan Zeng
Journal:  Mol Vis       Date:  2012-06-30       Impact factor: 2.367

7.  Serum levels of matrix metalloproteinase 2 and matrix metalloproteinase 9 elevated in polypoidal choroidal vasculopathy but not in age-related macular degeneration.

Authors:  Renpan Zeng; Feng Wen; Xiongze Zhang; Yu Su
Journal:  Mol Vis       Date:  2013-03-21       Impact factor: 2.367

8.  T-helper-associated cytokines expression by peripheral blood mononuclear cells in patients with polypoidal choroidal vasculopathy and age-related macular degeneration.

Authors:  Ying Yu; Xiang Rong Ren; Feng Wen; Hui Chen; Shao Bo Su
Journal:  BMC Ophthalmol       Date:  2016-06-07       Impact factor: 2.209

9.  Association of ARMS2 genotype with response to anti-vascular endothelial growth factor treatment in polypoidal choroidal vasculopathy.

Authors:  Un Chul Park; Joo Young Shin; Hum Chung; Hyeong Gon Yu
Journal:  BMC Ophthalmol       Date:  2017-12-07       Impact factor: 2.209

10.  Protocol for a randomised, double-masked, sham-controlled phase 4 study on the efficacy, safety and tolerability of intravitreal aflibercept monotherapy compared with aflibercept with adjunctive photodynamic therapy in polypoidal choroidal vasculopathy: the ATLANTIC study.

Authors:  João Pedro Marques; Cláudia Farinha; Miguel Ângelo Costa; Ângela Ferrão; Sandrina Nunes; Rufino Silva
Journal:  BMJ Open       Date:  2017-08-28       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.